Epigenetics: Rewriting the Future of Aging

by Emma Bardsley PhD

Epigenetics is a rapidly advancing field that is drawing significant investment, as it helps to reveal the causes of aging and exposes druggable targets for reversing and preventing cancer and age-related diseases.

Why Epigenetics Matters

The field of epigenetics is progressing quickly, presenting a novel and exciting approach for precision medicine by altering gene expression with high precision and reversibility without changing the underlying DNA sequence.

State of Play

Recent investments in the development of epigenetic therapeutics highlight growing confidence and the anticipated potential in the market.

• Chroma Medicine?has recently secured $135 million in Series B funding.?GV(formerly Google Ventures) led the new fundraising round to focus on epigenetic genome editing to precisely target disease-related genes.
• Epic Bio, founded by CRISPR pioneer Stanley Qi, has raised $55 million in Series A funding.
• Grail, a biotech company controversially acquired by?Illumina, has designed a test for detecting more than 50 cancers using DNA circulating in the bloodstream.

Read The Full Article (3 min read)

Biotech Primer Inc. provides engaging, interactive training courses tailored for non-scientists in the Biotechnology, Pharmaceutical, Molecular Diagnostics and Medical Device sectors. These courses, developed by industry experts, simplify complex scientific and regulatory concepts for professionals seeking to navigate and contribute effectively to the healthcare sector. With flexible learning options like on-demand online classes and live sessions, Biotech Primer has educated over 150,000 professionals since 2001, making it a go-to resource for understanding the science behind healthcare innovation.